CD8+ T cell exhaustion

CD8 + T cells are important for the protective immunity against intracellular pathogens and tumor. In the case of chronic infection or cancer, CD8 + T cells are exposed to persistent antigen and/or inflammatory signals. This excessive amount of signals often leads CD8 + T cells to gradual deteriorat...

Full description

Saved in:
Bibliographic Details
Published inSeminars in immunopathology Vol. 41; no. 3; pp. 327 - 337
Main Author Kurachi, Makoto
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2019
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1863-2297
1863-2300
1863-2300
DOI10.1007/s00281-019-00744-5

Cover

More Information
Summary:CD8 + T cells are important for the protective immunity against intracellular pathogens and tumor. In the case of chronic infection or cancer, CD8 + T cells are exposed to persistent antigen and/or inflammatory signals. This excessive amount of signals often leads CD8 + T cells to gradual deterioration of T cell function, a state called “exhaustion.” Exhausted T cells are characterized by progressive loss of effector functions (cytokine production and killing function), expression of multiple inhibitory receptors (such as PD-1 and LAG3), dysregulated metabolism, poor memory recall response, and homeostatic proliferation. These altered functions are closely related with altered transcriptional program and epigenetic landscape that clearly distinguish exhausted T cells from normal effector and memory T cells. T cell exhaustion is often associated with inefficient control of persisting infections and cancers, but re-invigoration of exhausted T cells with inhibitory receptor blockade can promote improved immunity and disease outcome. Accumulating evidences support the therapeutic potential of targeting exhausted T cells. However, exhausted T cells comprise heterogenous cell population with distinct responsiveness to intervention. Understanding molecular mechanism of T cell exhaustion is essential to establish rational immunotherapeutic interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ISSN:1863-2297
1863-2300
1863-2300
DOI:10.1007/s00281-019-00744-5